Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat

Biology of Reproduction

Volumn 67, Issue 6, 2002, Pages 1662-1670

  Espey, Lawrence L ^a   Richards, JoAnne S ^b  

^a TRINITY UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Follicle; Granulosa cells; Ovary; Ovulation; Progesterone

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; 5 AMINOLEVULINATE SYNTHASE; ADRENODOXIN; CARBONYL REDUCTASE; CD63 ANTIGEN; CHORIONIC GONADOTROPIN; CYCLOOXYGENASE 2; CYTOKINE; DISINTEGRIN; EARLY GROWTH RESPONSE FACTOR 1; EPIREGULIN; G PROTEIN COUPLED RECEPTOR; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE TRANSFERASE; GONADOTROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 1; LUTEINIZING HORMONE; MESSENGER RNA; METALLOPROTEINASE; METALLOTHIONEIN; PANCREATITIS ASSOCIATED PROTEIN; PHOSPHODIESTERASE; PROGESTERONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR;

CORPUS LUTEUM; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRANULOSA CELL; NONHUMAN; OVARY CELL; OVULATION; PRIORITY JOURNAL; RAT; SHORT SURVEY; STEROIDOGENESIS; STROMA CELL; THECA CELL; VASCULAR ENDOTHELIUM; ANIMAL; DRUG EFFECT; GENETICS; MEDLINE; METABOLISM; OVARY; REVIEW; TIME;

ANIMALS; CORPUS LUTEUM; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; GONADOTROPINS; GRANULOSA CELLS; MEDLINE; OVARY; OVULATION; RATS; STROMAL CELLS; THECA CELLS; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0036892310     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.005173     Document Type: Short Survey

References (118)

1. Espey LL, Lipner H. Measurement of intrafollicular pressure in the rabbit ovary. Am J Physiol 1963; 205:1067-1072.
2. Espey LL, Lipner H. Enzyme induced rupture of rabbit Graafian follicle. Am J Physiol 1965; 208:208-213.
3. Simpson KS, Byers MJ, Curry TE Jr. Spatiotemporal messenger ribonucleic acid expression of ovarian tissue inhibitors of metalloproteinases throughout the rat estrous cycle. Endocrinology 2001; 142: 2058-2069.
4. Koos RD. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: Potential roles in follicle rupture. Biol Reprod 1995; 52: 1426-1435.
5. Adashi EY. The potential role of interleukin-1 in the ovulatory process: An evolving hypothesis. Mol Cell Endocrinol 1998; 140:77-81.
6. Espey LL, Kalbaugh H, Vladu B, Armstrong M, Richards JS. Application of differential display to the isolation and identification of mRNA unique to ovulation. Biol Reprod 1995; 52(suppl 1):92.
7. Leo CP, Pisarska MD, Hsueh AJ. DNA array analysis of changes preovulatory gene expression in the rat ovary. Biol Reprod 2001; 65:269-276.
8. Lydon JP, DeMayo EJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995; 9:2266-2278.
9. Robker RL, Russell DL, Espey LL, Lydon JP, O'Malley BW, Richards JS. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and Cathepsin L proteases. Proc Natl Acad Sci U S A 2000; 97:4689-4694.
10. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83:473-482.
11. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czemiak PM, Gorry SA, Trzaskos JM. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378:406-409.
12. Davis BJ, Lennard DE, Lee CA, Tiano HF, Morham SG, Wetsel WC, Langenbach R. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1β. Endocrinology 1999; 140:2685-2695.
13. Espey LL. Ovulation. In: Knobil E, Neill JD (eds.), Encyclopedia of Reproduction, vol. 3. San Diego: Academic Press; 1999: 605-614.
14. Robker RL, Russell DL, Yoshioka S, Sharma SC, Lydon JP, O'Malley BW, Espey LL, Richards JS. Ovulation: A multi-gene, multi-step process. Steroids 2000; 65:559-570.
15. Espey LL. An overview of 37 years of research on ovulation. In: Adashi EY (ed.), Ovulation: Evolving Scientific and Clinical Concepts. New York: Springer-Verlag; 2001: 1-16.
16. Richards JS, Russell DL, Ochsner S, Espey LL. Ovulation: New dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol 2002; 64:69-92.
17. Richards JS, Russell DL, Ochsner S, Hieh M, Doyle KH, Falender AE, Lo YK, Sharma SC. Novel signaling pathways that control ovarian follicular development, ovulation and luteinization. Recent Prog Horm Res 2000; 57:195-220.
18. Espey LL, Yoshioka S, Russell D, Ujioka T, Vladu B, Skelsey M, Fujii S, Okamura H. Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature rat. Biol Reprod 2000; 62:390-397.
19. May BK, Bhasker CR, Bawden MJ, Cox TC. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis. Mol Biol Med 1990; 7:405-421.
20. Ferreira GC, Gong J. 5-Aminolevulinate synthase and the first step of heme biosynthesis. J Bioenerg Biomembr 1995; 27:151-159.
21. Sassa S, Nagai T. The role of heme in gene expression. Int J Hematol 1996; 63:167-178.
22. Oh-hama T. Evolutionary consideration on 5-aminolevulinate synthase in nature. Origins Life Evol Biosph 1997; 27:405-412.
23. Thunell S. Porphyrins, porphyrin metabolism and porphyrias. I. Update. Scand J Clin Lab Invest 2000; 60:509-540.
24. Aragones A, Gonzalez CB, Lantos CP. Sancovich HA. Progesterone, its A/B cis reduction and δ aminolevulinic acid synthetase in the developing hen. Acta Physiol Pharmacol Latinoam 1985; 35:379-397.
25. Iwasa F, Sassa S, Kappas A. The effects of acute-phase inducers and dimethyl sulphoxide on δ-aminolevulinate synthase activity in human HepG2 hepatoma cells. Biochem J 1989; 259:605-607.
26. Suhasini M, Boss GR, Pascual FE, Pilz RB. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: Correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression. Cell Growth Differ 1995; 6:1559-1566.
27. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP. New insights into the biology of the acute phase response. J Clin Immunol 1999; 19:203-214.
28. Lentsch AB, Ward PA. Regulation of inflammatory vascular damage. J Pathol 2000; 190:343-348.
29. Espey LL, Ujioka T, Russell D, Skelsey M, Vladu B, Robker RL, Okamura H, Richards JS. Induction of early growth response protein-1 gene expression in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Endocrinology 2000; 141:2385-2391.
30. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6:1355-1361.
31. Silverman ES, DeSanctis GT, Boyce J, Maclean JA, Jiao A, Green FH, Grasemann H, Faunce D, Fitzmaurice G, Shi GP, Stein-Streilein J, Milbrandt J, Collins T, Drazen JM. The transcription factor early growth-response factor 1 modulates tumor necrosis factor-α, immunoglobulin E, and airway responsiveness in mice. Am J Respir Crit Care Med 2001; 163:778-785.
32. Okada M, Fujita T, Sakaguchi T, Olson KE, Collins T, Stern DM, Yan SF, Pinsky DJ. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J 2001; 15: 2757-2759.
33. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog Nucleic Acids Res Mol Biol 1995; 50:191-224.
34. McMahon SB, Monroe JG. The role of early growth response gene 1 (EGR-1) in regulation of the immune response. J Leukocyte Biol 1996; 60:159-166.
35. Adashi EY. The potential relevance of cytokines to ovarian physiology: The emerging role of resident ovarian cells of the white blood cell series. Endocr Rev 1990; 11:454-464.
36. Terranova PF, Rice VM. Review: Cytokine involvement in ovarian processes. Am J Reprod Immunol 1997; 37:50-63.
37. Soltaninassab SR, Sekhar KR, Meredith MJ, Freeman ML. Multifaceted regulation of γ-glutamylcysteine synthetase. J Cell Physiol 2000; 182:163-170.
38. Wild AC, Mulcahy RT. Regulation of γ-glutamylcysteine synthetase subunit gene expression: Insights into transcriptional control of antioxidant defenses. Free Radic Res 2000; 32:281-301.
39. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 1998; 42:485-492.
40. Anderson ME. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 1998; 111-112:1-14.
41. Buetler TM. Identification of glutathione S-transferase isozymes and γ-glutamylcysteine synthetase as negative acute-phase proteins in rat liver. Hepatology 1998; 28:1551-1560.
42. Rahman I. Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid Redox Signal 1999; 1:425-447.
43. Clague N, Sevcik M, Stuart G, Brannstrom M, Janson PO, Jarrell JF. The effect of estrous cycle and buthionine sulfoximine on glutathione release from the in vitro perfused rat ovary. Reprod Toxicol 1992; 6:533-539.
44. Jarrell JF, Sevcik M, Stuart G. Regulation of total ovarian glutathione content in the rat. Reprod Toxicol 1992; 6:133-135.
45. Richards JS, Russell DL, Robker RL, Dajee M, Alliston TN. Molecular mechanisms of ovulation and luteinization. Mol Cell Endocrinol 1998; 145:47-54.
46. Joyce IM, Pendola FL, O'Brien M, Eppig JJ. Regulation of prostaglandin-endoperoxide synthase-2 messenger ribonucleic acid expression in mouse granulosa cells during ovulation. Endocrinology 2001; 142:3187-3197.
47. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999; 13:1035-1048.
48. Halter F, Tarnawski AS, Schmassmann A, Peskar BM. Cyclooxygenase-2 implications on maintenance of gastric mucosal integrity and ulcer healing: Controversial issues and perspectives. Gut 2001; 49:443-453.
49. Willoughby DA, Moore AR, Colville-Nash PR, Gilroy D. Resolution of inflammation. Int J Immunopharmacol 2000; 22:1131-1135.
50. Morteau O. Prostaglandins and inflammation: The cyclooxygenase controversy. Arch Immunol Ther Exp (Warsz) 2000; 48:473-480.
51. Taylor DS, Cheng X, Pawlowski JE, Wallace AR, Ferrer P, Molloy CJ. Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin. Proc Natl Acad Sci U S A 1999; 96:1633-1638.
52. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K, Hashimoto K. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000; 275:5748-5753.
53. Robert C, Gagne D, Bousquet D, Barnes FL, Sirard MA. Differential display and suppressive subtractive hybridization used to identify granulosa cell messenger RNA associated with bovine oocyte developmental competence. Biol Reprod 2001; 64:1812-1820.
54. Sasaki E, Pai R, Halter F, Komurasaki T, Arakawa T, Kobayashi K, Kuroki T, Tarnawski AS. Induction of cyclooxygenase-2 in a rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor. J Clin Gastroenterol 1998; 27(suppl 1):S21-S27.
55. Sherwood NM, Krueckl SL, McRory JE. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 2000: 21:619-670.
56. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: From structure to functions. Pharmacol Rev 2000; 52:269-324.
57. Shioda S. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors in the brain. Kaibogaku Zasshi 2000; 75: 487-507.
58. Gras S, Hannibal J, Georg B, Fahrenkrug J. Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells. Endocrinology 1996; 137:4779-4785.
59. Ko C, In YH, Park-Sarge OK. Role of progesterone receptor activation in pituitary adenylate cyclase activating polypeptide gene expression in rat ovary. Endocrinology 1999; 140:5185-5194.
60. Park JI, Kim WJ, Wang L, Park HJ, Lee J, Park JH, Kwon HB, Tsafriri A, Chun SY. Involvement of progesterone in gonadotrophin-induced pituitary adenylate cyclase-activating polypeptide gene expression in pre-ovulatory follicles of rat ovary. Mol Hum Reprod 2000; 6:238-245.
61. Koh PO, Kwak SD, Kang SS, Cho GJ, Chun SY, Kwon HB, Choi WS. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary. Mol Reprod Dev 2000; 55: 379-386.
62. Laceta J, Gomariz RP, Martinez C, Abad C, Ganea D, Delgado M. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP. Ann N Y Acad Sci 2000; 921:92-102.
63. Yoshioka S, Ochner S, Russell DL, Ujioka T, Fujii S, Richards JS, Espey LL. Expression of tumor necrosis factor-stimulated gene-6 in the rat ovary in response to an ovulatory dose of gonadotropin. Endocrinology 2000; 141:4114-4119.
64. Fulop C, Kamath RV, Li Y, Otto JM, Salustri A, Olsen BR, Glant TT, Hascall VC. Coding sequence, exon-intron structure and chromosomal localization of murine TNF-stimulated gene 6 that is specifically expressed by expanding cumulus cell-oocyte complexes. Gene 1997; 202:95-102.
65. Bardos T, Kamath RV, Mikecz K, Glant TT. Anti-inflammatory and chondroprotective effect of TSG-6 (tumor necrosis factor-α-stimulated gene-6) in murine models of experimental arthritis. Am J Pathol 2001; 159:1711-1721.
66. Hess KA, Chen L, Larsen WJ. Inter-α-inhibitor binding to hyaluronan in the cumulus extracellular matrix is required for optimal ovulation and development of mouse oocytes. Biol Reprod 1999; 61: 436-443.
67. Wisniewski HG, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN. TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-α-inhibitor and exerts a strong anti-inflammatory effect in vivo. J Immunol 1996; 156:1609-1615.
68. Ujioka T, Russell DL, Okamura H, Richards JS, Espey LL. Expression of regulator of G-protein signaling protein-2 gene in the rat ovary at the time of ovulation. Biol Reprod 2000; 63:1513-1517.
69. Hepler JR. Emerging roles for RGS proteins in cell signaling. Trends Pharmacol Sci 1999; 20:376-382.
70. DeVries L, Farquhar MG. RGS proteins: More than just GAPs for heterotrimeric G proteins. Trends Cell Biol 1999; 9:138-144.
71. Waterman MR, Simpson ER. Regulation of the biosynthesis of cytochromes P-450 involved in steroid hormone synthesis. Mol Cell Endocrinol 1985; 39:81-89.
72. Simpson ER, Mason JI, John ME, Zuber MX, Rodgers RJ, Waterman MR. Regulation of the biosynthesis of steroidogenic enzymes. J Steroid Biochem 1987; 27:801-805.
73. Hum DW, Miller WL. Transcriptional regulation of human genes for steroidogenic enzymes. Clin Chem 1993; 39:333-340.
74. Grinbereg AV, Hannemann F, Schiffier B, Muller J, Heinemann U, Bernhardt R. Adrenodoxin: Structure, stability, and electron transfer properties. Proteins 2000; 40:590-612.
75. Rodgers RJ, Lavranos TC, Rodgers HF, Young FM, Vella CA. The physiology of the ovary: Maturation of ovarian granulosa cells and a novel role for antioxidants in the corpus luteum. J Steroid Biochem Mol Biol 1995; 53:241-246.
76. Sugawara T, Holt JA, Driscoll D, Strauss III JF, Lin D, Miller WL, Patterson D, Clancy KP, Hart IM, Clark BJ, Stocco DM. Human steroidogenic acute regulatory protein: Functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci U S A 1995; 92:4778-4782.
77. 2-adrenergic receptor: Regulation of adrenodoxin and steroidogenic acute regulatory protein by adrenergic agents. Mol Cell Endocrinol 2000; 168:53-63.
78. Christenson LK, Strauss III JF. Steroidogenic acute regulatory protein (StAR) and the intramitochondrial translocation of cholesterol. Biochim Biophys Acta 2000; 1529:175-187.
79. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 2001; 63:193-213.
80. Ronen-Fuhrmann T, Timberg R, King SR, Hales KH, Hales DB, Stocco DM, Orly J. Spatio-temporal expression patterns of steroidogenic acute regulatory protein (StAR) during follicular development in the rat ovary. Endocrinology 1998; 139:303-315.
81. Chaffin CL, Dissen GA, Stouffer RL. Hormonal regulation of steroidogenic enzyme expression in granulosa cells during the peri-ovulatory interval in monkeys. Mol Hum Reprod 2000; 6:11-18.
82. Espey LL, Yoshioka S, Ujioka T, Fujii S, Richards JS. 3α-hydroxysteroid dehydrogenase messenger RNA transcription in the immature rat ovary in response to an ovulatory dose of gonadotropin. Biol Reprod 2001; 65:72-78.
83. Penning TM, Pawlowski JE, Schlegel BP, Jez JM, Lin HK, Hoog SS, Bennett MJ, Lewis M. Mammalian 3α-hydroxysteroid dehydrogenases. Steroids 1996; 61:508-523.
84. Ma H, Penning TM. Conversion of mammalian 3α-hydroxysteroid dehydrogenase to 20α-hydroxysteroid dehydrogenase using loop chimeras: Changing specificity from androgens to progestins. Proc Natl Acad Sci U S A 1999; 96:11161-11166.
85. Valent P, Schernthaner GH, Sperr WR, Fritsch G, Agis H, Willheim M, Buhring HJ, Orfao A, Escribano L. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev 2001; 179:74-81.
86. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: Molecular facilitators. FASEB J 1997; 11:428-442.
87. Vischer UM, Wagner DD. CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 1993; 82:1184-1191.
88. Espey LL, Lipner H. Ovulation. In: Knobil E, Neill JD (eds.), The Physiology of Reproduction. New York: Raven Press; 1994: 725-780.
89. Taylor CC, Limback D, Terranova PF. Src tyrosine kinase activity in rat thecal-interstitial cells and mouse TM3 Leydig cells is positively associated with cAMP-specific phosphodiesterase activity. Mol Cell Endocrinol 1997; 126:91-100.
90. Jin SL, Richard FJ, Kuo WP, D'Ercole AJ, Conti M. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci U S A 1999; 96:11998-12003.
91. Souness JE, Rao S. Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases. Cell Signal 1997; 9: 227-236.
92. Kasyapa CS, Stentz CL, Davey MP, Carr DW. Regulation of IL-15-stimulated TNF-α production by rolipram. J Immunol 1999; 163: 2836-2843.
93. Espey LL, Yoshioka S, Russell DL, Robker RL, Fujii S, Richards JS. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat. Biol Reprod 2000; 62:1090-1095.
94. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K. Molecular cloning of a gene encoding a new type of metallopro-teinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 1997; 272:556-562.
95. Tang BL. ADAMTS: A novel family of extracellular matrix proteases. Int J Biochem Cell Biol 2001; 33:33-44.
96. Mann JS, Kindy MS, Hyde JF, Cloark MR, Curry TE Jr. Role of protein synthesis, prostaglandins, and estrogen in rat ovarian metalloproteinase inhibitor production. Biol Reprod 1993; 48:1006-1013.
97. Simpson KS, Byers MJ, Curry TE Jr. Spatiotemporal messenger ribonucleic acid expression of ovarian tissue inhibitors of metalloproteinases throughout the rat estrous cycle. Endocrinology 2001; 142: 2058-2069.
98. Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64:1285-1296.
99. Forrest GL, Gonzalez B. Carbonyl reductase. Chem Biol Interact 2000; 129:21-40.
100. Wang D, Herman JP, Pritchard LM, Spitzer RH, Ahlbrand RL, Kramer GL, Petty F, Sallee FR, Richtand NM. Cloning, expression, and regulation of a glucocorticoid-induced receptor in rat brain: Effect of repetitive amphetamine. J Neurosci 2001; 21:9027-9035,
101. Katsumata N, Chakraborty C, Myal Y, Schroedter IC, Murphy LJ, Shiu RPC, Friesen HG. Molecular cloning and expression of peptide 23, a growth hormone-releasing hormone-inducible pituitary protein. Endocrinology 1995; 136:1332-1339.
102. Chakraborty C, Katsumata N, Myal Y, Schroedter IC, Brazeau P, Murphy LJ, Shiu RP, Friesen HG. Age-related changes in peptide-23/pancreatitis-associated protein and pancreatic stone protein/reg gene expression in the rat and regulation by growth hormone-releasing hormone. Endocrinology 1995; 136:1843-1849.
103. Frigerio J-M, Dusetti NJ, Garrido P, Dagorn J-C, Iovanna JL. The pancreatitis associated protein III (PAP III), a new member of the PAP gene family. Biochim Biophys Acta 1993; 1216:329-331.
104. Heller A, Fiedler F, Schmeck J, Luck V, Iovanna J, Koch T Pancreatitis-associated protein protects the lung from leukocyte-induced injury. Anesthesiology 1999; 91:1408-1414.
105. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000; 61:154-166.
106. Strange RC, Jones PW, Fryer AA. Glutathione S-transferase: Genetics and role in toxicology. Toxicol Lett 2000; 112-113:357-363.
107. Singh R, Wang B, Shirvaikar A, Khan S, Kamat S, Schelling JR, Konieczkowski M, Sedor JR. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 1999; 103:1561-1570.
108. Spiteri MA, Bianco A, Strange RC, Fryer AA. Polymorphisms at the glutathione S-transferase, GSTP1 locus: A novel mechanism for susceptibility and development of atopic airway inflammation. Allergy 2000; 55(suppl 61):15-20.
109. Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stoh SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol 2001; 21:69-73.
110. van Bladeren PJ. Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 2000; 129:61-76.
111. Miles AT, Hawksworth GM, Beattie JH, Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 2000; 35:35-70.
112. Moffatt P, Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab Rev 1997; 29:261-307.
113. Palmiter RD. The elusive function of metallothioneins. Proc Natl Acad Sci U S A 1998; 95:8428-8430.
114. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996; 273:1219-1221.
115. Olieveira-dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A 2000; 97:12272-12277.
116. Hasegawa T, Zhao L, Caron KM, Majdic G, Suzuki T, Shizawa S, Sasano H, Parker KL. Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice. Mol Endocrinol 2000; 14:1462-1471.
117. Shindo T, Kurihara H, Kuno K, Yokoyama H, Wada T, Kurihara Y, Imai T, Wang Y, Ogata M, Nishimatsu H, Moriyama N, Oh-hashi Y, Morita H, Ishikawa T, Nagai R, Yazaki Y, Matsushima K. ADAMTS1: A metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest 2000; 105: 1335-1337.
118. Nothnick WB, Soloway P, Curry TE Jr. Assessment of the role of tissue inhibitor of metalloproteinase-1 (TIMP-1) during the periovulatory period in female mice lacking a functional TIMP-1 gene. Biol Reprod 1997; 56:1181-1188.